drugset / Trial / NCT02155803

ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study

NCT02155803 ↗

Phase 2/3 Unknown 10 enrolled Albany Medical College
NaSingle-groupOpen-labelTreatment

Summary

ACTHAR Gel has activity in sarcoidosis associated hypercalciuria and calcium dysregulation.

Timeline

Start
2015-02
Primary completion
2015-06
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject adrenocorticotropic hormone Unknown 80 iu Subcutaneous